vimarsana.com

Page 51 - உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் வழிநடத்தியது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 news: Cases in India hit record high as Kumbh Mela begins

REUTERS/Danish Siddiqui Latest coronavirus news as of 5pm on 12 April As millions gather to celebrate Kumbh Mela, India’s coronavirus cases surge, overtaking Brazil in total number of infections India reported a record increase of 168,912 new coronavirus cases on 12 April, bringing the country’s total number of cases since the start of the pandemic to about 13.53 million. India’s tally is now the second-highest in the world, narrowly overtaking Brazil, but remaining below the 31.2 million cases reported so far in the US.  Advertisement According to estimates from Johns Hopkins University, infections in India are on course to double in two months. Some officials have expressed concerns about crowding at religious festivals and political rallies. In the northern city of Haridwar almost a million people gathered by the Ganges river on 12 April to participate in the Hindu festival Kumbh Mela. “The police are continuously appealing to people to maintain social distancing,

If Not The WHO, Then Who? Critics Say COVID-19 Investigation Requires A New Treaty, A Do-Over, Or Better Intelligence

Font Size: The WHO-led team investigating COVID-19 lacked the power “to demand transparency and accountability,” according to an article in Foreign Policy. A new pandemic treaty would help inspectors gain access, with sanctions to enforce cooperation, supporters say. Such a treaty might have prevented the pandemic, according to a WHO advisory committee member. Critics of the World Health Organization-led team’s report on the origins of COVID-19 have several proposals to improve the investigation of pandemics, including a new treaty that would empower WHO to do a better investigation. The U.S. and other nations have criticized the WHO report on COVID-19’s origin released on March 30 as lacking scientific rigor due to China blocking access to information, with some proposing that the WHO appoint a different team or calling on the U.S. National Institutes of Health to take over the investigation.

Covid-19 news: EU drugs regulator reviewing Johnson & Johnson vaccine

Stephen Zenner/SOPA Images/Shutterstock Latest coronavirus news as of 5pm on 9 April The EU’s medicines regulator is reviewing a small number of reports of rare blood clots in people who received the Johnson & Johnson vaccine The European Union’s medicines regulator is reviewing four reported cases of rare blood clots associated with low levels of platelets – small particles in the blood that normally help in clotting – including one case which was fatal, in people who received the Johnson & Johnson covid-19 vaccine. The European Medicines Agency (EMA) is also reviewing five reported cases of a bleeding condition, called capillary leak syndrome, in people who received the Oxford/AstraZeneca covid-19 vaccine. “At this stage, it is not yet clear whether there is a causal association” between the vaccines and the reported conditions, the EMA said. Both the Oxford/AstraZeneca and Johnson & Johnson vaccines are based on viral vector technologies, which use inactivated cold

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.